Omnia Family Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.06M | Buy |
4,219
+25
| +0.6% | +$5.38K | 0.28% | 31 |
|
|
2026
Q1 | $912K | Sell |
4,194
-848
| -17% | -$188K | 0.29% | 30 |
|
|
2025
Q4 | $1.15M | Hold |
5,042
| – | – | 0.34% | 31 |
|
|
2025
Q3 | $1.17M | Buy |
5,042
+570
| +13% | +$116K | 0.38% | 30 |
|
|
2025
Q2 | $830K | Sell |
4,472
-317
| -7% | -$58.9K | 0.3% | 32 |
|
|
2025
Q1 | $1M | Buy |
4,789
+627
| +15% | +$122K | 0.42% | 26 |
|
|
2024
Q4 | $740K | Buy |
4,162
+71
| +2% | +$13.1K | 0.31% | 32 |
|
|
2024
Q3 | $808K | Buy |
4,091
+317
| +8% | +$59.2K | 0.35% | 31 |
|
|
2024
Q2 | $647K | Sell |
3,774
-65
| -2% | -$10.8K | 0.27% | 37 |
|
|
2024
Q1 | $699K | Buy |
3,839
+343
| +10% | +$59.1K | 0.33% | 32 |
|
|
2023
Q4 | $542K | Sell |
3,496
-332
| -9% | -$48.4K | 0.28% | 34 |
|
|
2023
Q3 | $571K | Buy |
3,828
+357
| +10% | +$52.4K | 0.35% | 32 |
|
|
2023
Q2 | $468K | Sell |
3,471
-171
| -5% | -$25.1K | 0.32% | 40 |
|
|
2023
Q1 | $580K | Buy |
3,642
+114
| +3% | +$17.4K | 0.45% | 27 |
|
|
2022
Q4 | $570K | Buy |
3,528
+57
| +2% | +$8.74K | 0.46% | 28 |
|
|
2022
Q3 | $466K | Hold |
3,471
| – | – | 0.38% | 29 |
|
|
2022
Q2 | $532K | Hold |
3,471
| – | – | 0.39% | 29 |
|
|
2022
Q1 | $563K | Sell |
3,471
-230
| -6% | -$33.4K | 0.37% | 33 |
|
|
2021
Q4 | $501K | Buy |
3,701
+217
| +6% | +$25.6K | 0.3% | 39 |
|
|
2021
Q3 | $376K | Hold |
3,484
| – | – | 0.26% | 51 |
|
|
2021
Q2 | $392K | Hold |
3,484
| – | – | 0.25% | 48 |
|
|
2021
Q1 | $377K | Hold |
3,484
| – | – | 0.28% | 48 |
|
|
2020
Q4 | $373K | Sell |
3,484
-200
| -5% | -$19.2K | 0.34% | 49 |
|
|
2020
Q3 | $323K | Hold |
3,684
| – | – | 0.31% | 49 |
|
|
2020
Q2 | $362K | Buy |
3,684
+9
| +0.2% | +$792 | 0.35% | 44 |
|
|
2020
Q1 | $280K | Buy |
3,675
+200
| +6% | +$17K | 0.29% | 52 |
|
|
2019
Q4 | $308K | Hold |
3,475
| – | – | 0.14% | 71 |
|
|
2019
Q3 | $263K | Sell |
3,475
-18
| -0.5% | -$1.23K | 0.19% | 67 |
|
|
2019
Q2 | $254K | Hold |
3,493
| – | – | 0.13% | 82 |
|
|
2019
Q1 | $282K | Hold |
3,493
| – | – | 0.14% | 70 |
|
|
2018
Q4 | $322K | Hold |
3,493
| – | – | 0.17% | 62 |
|
|
2018
Q3 | $330K | Hold |
3,493
| – | – | 0.15% | 62 |
|
|
2018
Q2 | $324K | Hold |
3,493
| – | – | 0.15% | 59 |
|
|
2018
Q1 | $331K | Sell |
3,493
-319
| -8% | -$35K | 0.15% | 57 |
|
|
2017
Q4 | $369K | Buy |
3,812
+319
| +9% | +$30.1K | 0.17% | 53 |
|
|
2017
Q3 | $310K | Sell |
3,493
-158
| -4% | -$12K | 0.15% | 57 |
|
|
2017
Q2 | $265K | Sell |
3,651
-2,443
| -40% | -$164K | 0.13% | 69 |
|
|
2017
Q1 | $397K | Sell |
6,094
-38
| -0.6% | -$2.39K | 0.19% | 48 |
|
|
2016
Q4 | $384K | Buy |
+6,132
| New | +$374K | 0.19% | 54 |
|
Other funds holding ABBV
ECSS
ATO
Omnia Family Wealth's ABBV Position: Q2 2026 in Review
Omnia Family Wealth increased its AbbVie (ABBV) stake by 0.6% in Q2 2026, buying an estimated $5.38K and bringing the position to 4,219 shares worth $1.06M. The position accounts for 0.28% of the portfolio, ranked #31.
Omnia Family Wealth first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.17M in Q3 2025. 1,853 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Omnia Family Wealth held 4,219 shares of AbbVie worth $1.06M as of Q2 2026.
- Omnia Family Wealth bought 25 AbbVie shares in Q2 2026, an estimated $5.38K.
- AbbVie made up 0.28% of Omnia Family Wealth's portfolio in Q2 2026, its #31 holding.
- Omnia Family Wealth first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
- Omnia Family Wealth's AbbVie position peaked at $1.17M in Q3 2025.
- 1,853 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Omnia Family Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.